Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
Logo Image
|Articles|May 6, 2022

Phesi Global Analysis of 2.5 Million Patients Finds Participants in Breast Cancer Clinical Trials Are Getting Younger

New analysis from Phesi Inc. has found that since 2014 the number of women younger than 60 years of age participating in breast cancer clinical trials has increased dramatically, with an overall increase in trial participants younger than 60 years of age from 30% to about 80%. The results emerge following a global analysis of 2,511,046 breast cancer patients from 4,674 investigator sites.

Read more about the analysis from Phesi here.

Related to this article

View more
Where AI Leads in Trial Design—and Where Humans Still Need To
Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.
Read more